Close Menu

All of the Dots

The New York Times profiles Eric Schadt, the chief scientific officer of Pacific Biosciences, from his days in the Air Force to working with his new nonprofit, Sage Bionetworks. In the article Schadt is heralded for his unconventional approach — both to his research and attire. The new venture, Sage, has received data and hardware from Merck's Rosetta subsidiary, where Schadt worked until recently.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.